Mar. 21 at 10:25 PM
$ALT Durso could be playing the Regeneron playbook to the letter: leveraging his Sanofi pedigree to use authorized shares as "partnership bait," just as REGN did at
$5/share (over 100% authorization) to lock in Sanofi and fuel a 24,000% run to
$1,200. By authorizing ALT's shares now, could he be reloading the war chest to snare a BP partner for Pemvi? PMI just got a 100% increase from 150m to 300m/shares and ATYR is looking for 100% increase from 170m to 340m in May. Seems like a quick way to clear the legal path to raise money in a hurry for something like an expensive trial should share price move up. No question dilution is no fun but ask REGN shareholders what they thought - you can find them on their 300 foot yachts in the south of France or at a Lambo dealership near you.
